A cocktail of problems hit the industry, including demand for wine falling as more people drink craft beer.

SAVE 49%: Secure access to the best gaming deals with ExpressVPN. A one-year subscription to

European wines are finally being forced to reveal their ingredients to customers, but only on a website -- not on the bottle...

Asus released a critical firmware update for 19 of its wireless routers that fixes nine

Parents in the southern California city of Temecula are pushing back against the local school board's recent decision to reject a social studies curriculum that includes gay rights after some board members claimed there was not enough parental involvement in the process and made comments attacking gay rights activist and politician Harvey Milk.

The head of the United Nations food agency says a global hunger crisis has left more than 700 million people not knowing when or if they will eat again

It is Wednesday, my dudes, and there's a brand new Wordle. As always, we're here

Montana banned TikTok and creators within the state are fighting back. Last week, Montana Governor

Kailyn Lowry revealed that her son left a note saying, 'Use a condom before you end up with yet another kid'

'I’ve always been so inspired by beauty and fashion from the UK, and how bold and innovative it is,' said

Using existing drugs to treat cervical cancer before standard treatment could lead to a 35% reduction in the risk of relapse or death, a new study suggests. Researchers from the UCL Cancer Institute and UCLH looked into whether a short course of induction chemotherapy (IC), where a drug is used to destroy as many cancer cells as possible, before chemoradiation (CRT), could help with this. Here’s everything you need to know about the findings… What is cervical cancer? According to the NHS website, cervical cancer is a type of cancer found anywhere near the cervix – the opening between the vagina and the womb (uterus), which is also known as the neck of the womb. Most cervical cancers grow very slowly and are caused by an infection from specific types of human papillomavirus (HPV) and mostly affect women under the age of 45. According to Jo’s Cervical Cancer Trust, symptoms include vaginal bleeding that is unusual to you, changes to vaginal discharge, discomfort during sex and pain in your lower back or pelvis. Changes to cells can be spotted by a cervical screening, and then treated before they turn into cancer. There are around 3,200 new cases every year in the UK, with the five-year survival rate being around 70%, according to Cancer Research UK. CRT has been the standard treatment for cervical cancer patients since 1999, but even though there have been overall significant developments in radiation therapy techniques, up to 30% of people experience their cancer coming back. What did the research involve? Over a 10-year period, 500 patients who had been diagnosed with cervical cancer – that was large enough to see without a microscope but hadn’t spread to other parts of the body – took part in the Interlace trial at hospitals in the UK, Mexico, India, Italy and Brazil. Researchers looked into whether a short course of IC before CRT could reduce rates of relapse and death. What results were found? After five years, researchers discovered that 80% of the people who received a combination of chemotherapy and radiotherapy were alive, whilst 73% had not seen their cancer return or spread. A major benefit, according to researchers, is that it can be incorporated into standard of care treatment relatively quickly, because cheap, accessible and already-approved ingredients such as carboplatin and paclitaxel are needed for IC. “Our trial shows that this short course of additional chemotherapy delivered immediately before the standard CRT can reduce the risk of the cancer returning or death by 35%,” said Dr Mary McCormack, lead investigator of the trial from UCL Cancer Institute and UCLH. “This is the biggest improvement in outcome in this disease in over 20 years. “I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere. “We couldn’t have done this without the generous support of Cancer Research UK.” Why is the research important? Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: “Timing is everything when you’re treating cancer. The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial. “A growing body of evidence is showing the value of additional rounds of chemotherapy before other treatments like surgery and radiotherapy in several other cancers. “Not only can it reduce the chances of cancer coming back, it can be delivered quickly using drugs already available worldwide. “We’re excited for the improvements this trial could bring to cervical cancer treatment and hope short courses of induction chemotherapy will be rapidly adopted in the clinic.”

Whether he's a new dad or a seasoned pro, there's one common denominator for gifts that fathers appreciate: comfy clothes that make him feel good with minimal effort. This is where Lululemon — purveyor of effortlessly cool activewear that just so happens to be the perfect casual-dad attire — comes into play. If your pops has been wearing the same old sweatpants for 20-plus years, then Lululemon is the answer to any Father's Day gifting dilemma.